(Q6456080)

L-741,626 (English)

3 October 2016

C₂₀H₂₁ClN₂O

1 reference

L-741,626 (English)

3 October 2016

C1CN(CCC1(C2=CC=C(C=C2)Cl)O)CC3=CNC4=CC=CC=C43

1 reference

L-741,626 (English)

physically interacts with

3 October 2016

5-hydroxytryptamine receptor 2A

subject has role

antagonist

1 reference

stated in

5-hydroxytryptamine receptor 2B

17 August 2016

subject has role

antagonist

1 reference

stated in

17 August 2016

1 reference

17 August 2016

1 reference

Medical Subject Headings

MeSH descriptor ID

C104750

InChI=1S/C20H21ClN2O/c21-17-7-5-16(6-8-17)20(24)9-11-23(12-10-20)14-15-13-22-19-4-2-1-3-18(15)19/h1-8,13,22,24H,9-12,14H2

15 March 2018

Identifiers

InChI

1 reference

L-741,626 (English)

3 October 2016

2 references

L-741,626 (English)

3 October 2016

ChEBI release 2020-09-01

CAS Registry Number

81226-60-0

1 reference

https://commonchemistry.cas.org/detail?cas_rn=81226-60-0

8 April 2021

1 reference

L-741,626 (English)

3 October 2016

2 references

L-741,626 (English)

3 October 2016

ChEBI ID

92090

mapping relation type

2 references

4-(4-chlorophenyl)-1-(1H-indol-3-ylmethyl)-4-piperidinol (English)

3 October 2016

International Chemical Identifier

InChI

InChI=1S/C20H21ClN2O/c21-17-7-5-16(6-8-17)20(24)9-11-23(12-10-20)14-15-13-22-19-4-2-1-3-18(15)19/h1-8,13,22,24H,9-12,14H2

1 reference

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

CHEMBL445102 (English)

3 October 2016

1 reference

2 references

DSSTOX compound identifier

DTXCID60153465

0 references

1 reference

stated in

L-741,626 (English)

3 October 2016

1 reference

Medical Subject Headings

MeSH descriptor ID

C104750

Human Metabolome Database ID

14 March 2018

HMDB0253858

2 references

based on heuristic

inferred from InChIKey

UNII

WTW4A6SW92

1 reference